Ad
related to: beta blockers used for arrhythmiaGoodRx was honored as dot.LA’s Startup of the Year for 2020. - dot.LA
- Healthcare Professionals
GoodRx® Can Help You Get Major
Savings For Your Patients
- Find A Pharmacy Near Me
Search & Compare the Lowest Prices
to Save at Your Favorite Pharmacy
- Transparent Pricing
Healthcare is confusing. We make it
simple. Use GoodRx to start saving.
- Visit Our FAQs
Have Questions? We've Got Answers.
See Our FAQs to Learn More Now!
- Healthcare Professionals
Search results
Results from the WOW.Com Content Network
Beta blockers have also been used for the treatment of schizoid personality disorder. [105] However, there is limited evidence supporting the efficacy of supplemental beta blocker use in addition to antipsychotic drugs for treating schizophrenia. [106] [107] Contrast agents are not contraindicated in those receiving beta blockers. [108]
Antiarrhythmic agents, also known as cardiac dysrhythmia medications, are a class of drugs that are used to suppress abnormally fast rhythms (tachycardias), such as atrial fibrillation, supraventricular tachycardia and ventricular tachycardia.
Bisoprolol, sold under the brand name Zebeta among others, is a beta blocker which is selective for the beta-1 receptor [7] and used for cardiovascular diseases, [7] including tachyarrhythmias, high blood pressure, angina, and heart failure. [7] [8] It is taken by mouth. [7]
Beta-blockers. Calcium-channel blockers. Disopyramide. Dilated cardiomyopathy is one of the main causes of heart failure. It occurs in about 1 in 2,500 people. Treatment for dilated cardiomyopathy ...
Betaxolol is a selective beta 1 receptor blocker used in the treatment of hypertension and angina. [1] ... cardiac problems such as arrhythmia, bundle branch block, ...
Acebutolol, [1] sold under the brand names Sectral among others, is a beta blocker for the treatment of hypertension and arrhythmias. Acebutolol is a cardioselective beta-1 blocker and has intrinsic sympathetic activity. It is commonly used in the treatment of angina. It was patented in 1967 and approved for medical use in 1973. [2]
Figure 1: The chemical structure of dichloroisoprenaline or dichloroisoproterenol (), abbreviated DCI — the first β-blocker to be developed. β adrenergic receptor antagonists (also called beta-blockers or β-blockers) were initially developed in the 1960s, for the treatment of angina pectoris but are now also used for hypertension, congestive heart failure and certain arrhythmias. [1]
Nadolol is the preferred beta-blocker in the management of patients with LQTS for prevention of ventricular arrhythmia. It is more efficacious than selective beta blockers or propranolol in the prevention of breakthrough cardiac events. [12]